IO Biotech, Inc. IOBT 深 沪
已收盘 02-06 16:00:00 美东时间
0.35
+0.030
+9.27%
华盛通- 最 高0.3541
- 今 开0.3081
- 成交量 691.37万股
- 最 低 0.3042
- 昨 收 0.3203
- 总市值 2518.21万
- 52周最高 2.79
- 市盈率 静 --
- 换手率 9.61%
- 52周最低 0.2053
- 委 比 -79.14%
- 总股本 7194.88万
- 历史最高 17.88
- 量 比 3.31
- 振 幅 15.58%
- 历史最低 0.2053
- 每 手 1
- 风险率 0.48%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多IO Biotech launches strategic review amid major restructuring
IO Biotech ( ($IOBT) ) just unveiled an update. On January 21, 2026, IO Biotech...
01-31 06:18
IO Biotech Engages Raymond James and Reduces Workforce
IO Biotech Engages Raymond James and Reduces Workforce IO Biotech Inc. announced that it has engaged Raymond James & Associates, Inc. as its exclusive financial advisor to assist in the exploration of strategic alternatives. The company also reported the implementation of cost-containment and cash c
01-31 05:54
IO Biotech Provides Corporate Update
<p>IO Biotech has retained Raymond James as its financial advisor to explore strategic alternatives. The company is also implementing cost-cutting measures, including workforce reduction, to conserve cash while evaluating its options. Based in Copenhagen and New York, IO Biotech focuses on developing immune-modulatory cancer vaccines using its T-win platform. The company emphasizes forward-looking statements are subject to risks and uncertainties...
01-30 13:05
美股大行评级 | 斯伦贝谢、SouthState Bank、西屋制动、特里科银行获多家大行上调目标价；苹果、meta、微软等绩前遭下调目标价
今日重点评级关注：Oppenheimer：维持Pelthos Therapeutics"跑赢大市"评级，目标价从57美元升至60美元；Small Cap Consumer Research：维持Lands' End"买入"评级，目标价从20美元升至45美元
01-27 10:02
Piper Sandler Downgrades IO Biotech to Neutral, Lowers Price Target to $0.5
Piper Sandler analyst Allison Bratzel downgrades IO Biotech (NASDAQ:IOBT) from Overweight to Neutral and lowers the price target from $3 to $0.5.
01-27 02:03
Why High Roller Technologies Shares Are Trading Higher By 30%; Here Are 20 Stocks Moving Premarket
Shares of High Roller Technologies Inc (NYSE:ROLR) rose sharply in pre-market t...
01-22 17:46
BUZZ-U.S. STOCKS ON THE MOVE-Oklo, AMD, Lam Research
BUZZ-U.S. STOCKS ON THE MOVE-Oklo, AMD, Lam Research Eikon search string for individual stock moves: STXBZ The Day Ahead newsletter: https://refini.tv/3LI4BU7 The Morning News Call newsletter: https://refini.tv/3dKUyB8 U.S. stocks staged a modest recovery on Wednesday after the sharpest equities se
01-22 02:53
12 Health Care Stocks Moving In Wednesday's Intraday Session
Gainers PAVmed (NASDAQ:PAVM) stock increased by 250.7% to $21.71 during Wednes...
01-22 01:05
IO Biotech to explore strategic alternatives
IO Biotech (IOBT) plans to explore a range of strategic alternatives, including a merger, a business combination, a sale of assets, or a liquidation and dissolution, to maximize stockholder value. The...
01-21 18:37
IO Biotech Considers Strategic Options, Including Possible Sale or Wind-Down
IO Biotech (NASDAQ:IOBT), a clinical-stage biopharmaceutical company developing novel, immune-modulatory, off-the-shelf therapeutic cancer vaccines, today announced that the company intends to explore a range of
01-21 18:32
